Have a feature idea you'd love to see implemented? Let us know!

ELMD Electromed Inc

Price (delayed)

$28.07

Market cap

$237.42M

P/E Ratio

37.43

Dividend/share

N/A

EPS

$0.75

Enterprise value

$223.55M

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, ...

Highlights
The net income has surged by 100% year-on-year and by 26% since the previous quarter
Electromed's EPS has soared by 92% YoY and by 25% from the previous quarter
The equity rose by 9% year-on-year but it has declined by 7% since the previous quarter
ELMD's P/E is 38% above its last 4 quarters average of 27.1 and 15% above its 5-year quarterly average of 32.5
The company's quick ratio fell by 8% YoY and by 4.9% QoQ

Key stats

What are the main financial stats of ELMD
Market
Shares outstanding
8.46M
Market cap
$237.42M
Enterprise value
$223.55M
Valuations
Price to earnings (P/E)
37.43
Price to book (P/B)
5.84
Price to sales (P/S)
4.21
EV/EBIT
24.98
EV/EBITDA
22.95
EV/Sales
3.92
Earnings
Revenue
$57.06M
EBIT
$8.95M
EBITDA
$9.74M
Free cash flow
$11.41M
Per share
EPS
$0.75
Free cash flow per share
$1.33
Book value per share
$4.8
Revenue per share
$6.66
TBVPS
$5.63
Balance sheet
Total assets
$48.92M
Total liabilities
$7.43M
Debt
$0
Equity
$41.49M
Working capital
$33.59M
Liquidity
Debt to equity
0
Current ratio
5.53
Quick ratio
4.88
Net debt/EBITDA
-1.42
Margins
EBITDA margin
17.1%
Gross margin
76.6%
Net margin
11.3%
Operating margin
14.7%
Efficiency
Return on assets
13.1%
Return on equity
15.3%
Return on invested capital
31.3%
Return on capital employed
21.6%
Return on sales
15.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELMD stock price

How has the Electromed stock price performed over time
Intraday
-3.9%
1 week
-2.84%
1 month
23.11%
1 year
172.52%
YTD
157.29%
QTD
30.74%

Financial performance

How have Electromed's revenue and profit performed over time
Revenue
$57.06M
Gross profit
$43.72M
Operating income
$8.38M
Net income
$6.47M
Gross margin
76.6%
Net margin
11.3%
ELMD's operating income has surged by 104% year-on-year and by 27% since the previous quarter
The net income has surged by 100% year-on-year and by 26% since the previous quarter
Electromed's operating margin has surged by 77% YoY and by 23% QoQ
Electromed's net margin has soared by 74% YoY and by 20% from the previous quarter

Growth

What is Electromed's growth rate over time

Valuation

What is Electromed stock price valuation
P/E
37.43
P/B
5.84
P/S
4.21
EV/EBIT
24.98
EV/EBITDA
22.95
EV/Sales
3.92
Electromed's EPS has soared by 92% YoY and by 25% from the previous quarter
ELMD's P/E is 38% above its last 4 quarters average of 27.1 and 15% above its 5-year quarterly average of 32.5
The price to book (P/B) is 101% higher than the 5-year quarterly average of 2.9 and 83% higher than the last 4 quarters average of 3.2
The equity rose by 9% year-on-year but it has declined by 7% since the previous quarter
The stock's price to sales (P/S) is 68% more than its 5-year quarterly average of 2.5 and 68% more than its last 4 quarters average of 2.5
ELMD's revenue is up by 15% year-on-year and by 4.3% since the previous quarter

Efficiency

How efficient is Electromed business performance
The ROIC has soared by 116% YoY and by 32% from the previous quarter
Electromed's ROS has soared by 83% YoY and by 22% from the previous quarter
The company's return on assets has surged by 77% YoY and by 22% QoQ
The ROE has soared by 74% YoY and by 23% from the previous quarter

Dividends

What is ELMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELMD.

Financial health

How did Electromed financials performed over time
Electromed's total liabilities has increased by 27% YoY but it has decreased by 3.4% QoQ
The current ratio has declined by 12% year-on-year and by 3.8% since the previous quarter
Electromed's debt is 100% less than its equity
The equity rose by 9% year-on-year but it has declined by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.